3/5/26 17:01 | 3/3/26 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | 2 | S | -2,897 | 650.89 | 0 | -4 | | 20 | D | | | | | | | | | | | | | | |
3/3/26 16:16 | 3/2/26 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | 2 | S.d | -96 | 9.48 | 0 | -10 | | 94 | D | | | | | | | | | | | | | | |
3/2/26 17:00 | 2/26/26 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | 1 | S.d | -15,338 | 657.55 | 0 | -23 | | 84 | D | | | | | | | | | | | | | | |
2/19/26 18:00 | 2/17/26 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Erickson Michael G | ME | O | EVP | 1 | S.d | -3,370 | 627.38 | 0 | -5 | | 15 | D | | | | | | | | | | | | | | |
2/19/26 18:00 | 2/17/26 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | 1 | S.d | -920 | 628.62 | 0 | -1 | | 9 | D | | | | | | | | | | | | | | |
2/11/26 17:01 | 2/10/26 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | EVP | 1 | S.d | -7,337 | 646.72 | 0 | -11 | | 10 | D | | | | | | | | | | | | | | |
2/2/26 20:51 | 1/30/26 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | 2 | S.d | -1,554 | 78.04 | 0 | -20 | | 133 | D | | | | | | | | | | | | | | |
1/7/26 16:05 | 1/5/26 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | 1 | S | -314 | 9.21 | 0 | -34 | | 1,072 | D | | | | | | | | | | | | | | |
1/7/26 16:05 | 1/5/26 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schultes Birgit C | MA | O | EVP,Chie | 1 | S | -78 | 9.21 | 0 | -9 | | 99 | D | | | | | | | | | | | | | | |
1/7/26 16:05 | 1/5/26 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | 1 | S | -96 | 9.21 | 0 | -10 | | 102 | D | | | | | | | | | | | | | | |
1/7/26 16:04 | 1/5/26 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | 1 | S | -110 | 9.21 | 0 | -12 | | 121 | D | | | | | | | | | | | | | | |
1/7/26 16:02 | 1/5/26 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dulac Edward J III | MA | O | EVP,CFO | 1 | S | -59 | 9.21 | 0 | -6 | | 100 | D | | | | | | | | | | | | | | |
1/7/26 16:01 | 1/5/26 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dube Michael P | MA | O | VP,Chief | 1 | S | -28 | 9.21 | 0 | -3 | | 52 | D | | | | | | | | | | | | | | |